Abstract: . . .  separate envelope. C. MAILING The application must be received no later than October 10, 2006 @ 4:00 p.m . at the following address: Research Advocacy and Health Promotion Heart and Stroke Foundation of Ontario Suite 1300, P.O. Box 2414 Yonge Eglinton Centre 2300 Yonge Street Toronto, Ontario M4P 1E4 Attention: Social Determinants of Hypertension . . .
. . .  for the project. 6 Page 10 Common CV Name 13. For the principal investigator and all co-applicants listed on page 1, please complete and attach a printed copy of the Common CV form. This is a web-based form, which will allow you to enter your CV information online. Please refer to the website ( www.commoncv.net ) for further . . .
. . .  envelope. C. MAILING The application must be received no later than October 10, 2006 @ 4:00 p.m . at the following address: Research Advocacy and Health Promotion Heart and Stroke Foundation of Ontario Suite 1300, P.O. Box 2414 Yonge Eglinton Centre 2300 Yonge Street Toronto, Ontario M4P 1E4 Attention: Social Determinants of Hypertension Special Competition . . .
. . .  envelope. C. MAILING The application must be received no later than October 10, 2006 @ 4:00 p.m . at the following address: Research Advocacy and Health Promotion Heart and Stroke Foundation of Ontario Suite 1300, P.O. Box 2414 Yonge Eglinton Centre 2300 Yonge Street Toronto, Ontario M4P 1E4 Attention: Social Determinants of Hypertension Special Competition . . .
. . .  following address: Research Advocacy and Health Promotion Heart and Stroke Foundation of Ontario Suite 1300, P.O. Box 2414 Yonge Eglinton Centre 2300 Yonge Street Toronto, Ontario M4P 1E4 Attention: Social Determinants of Hypertension Special Competition Page 2 Name Date Short title of the proposed research LIST . . .
. . .  knowledge to date, methods to be used, anticipated results and conclusions, possible problems and pertinent references. Clearly demonstrate throughout the summary how the proposed research addresses Social Determinants of Hypertension within each of the two phases . Ensure that Phase I informs Phase II with novel information or novel analysis (not information already available). This section must . . .
--2480,6,207,2932,12401